한글목차

인간 오가노이드 세계 시장 규모는 2024년 5억 1,024만 달러로 평가되었고, 예측 기간 동안 4.15%의 연평균 복합 성장률(CAGR)로 2030년에는 6억 4,379만 달러에 달할 것으로 예상됩니다.

세계 인간 오가노이드 시장은 생명공학의 발전, 개인 맞춤형 의료에 대한 수요 증가, 질병 모델링 및 신약개발에 초점을 맞춘 연구 활동 증가로 인해 크게 성장하고 있습니다. 줄기세포에서 배양된 인간 오가노이드의 3차원 미니어처인 오가노이드는 기존 방식에 비해 보다 정밀하고 윤리적으로 지속 가능한 방식으로 인간 생물학을 연구할 수 있는 혁신적인 플랫폼을 제공합니다. 이 시장은 제약, 생명공학, 학술 분야에서 견인력을 높이고 있으며, 연구, 약물 시험, 재생의료에 유망한 길을 제공합니다.

시장 성장 촉진요인

헬스케어 산업의 성장

주요 시장 이슈

높은 개발 및 연구 비용

주요 시장 동향

신약 개발 및 검사 분야에서의 용도 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 인간 오가노이드 시장에 미치는 영향

제5장 세계의 인간 오가노이드 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유래별(성체 줄기세포, 유도만능 줄기세포, 배성줄기세포, 기타)
  • 장기별(위 모델, 장 모델, 간 모델, 췌장 모델, 폐 모델, 뇌 모델, 신장 모델, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 인간 오가노이드 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 인간 오가노이드 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 인간 오가노이드 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 인간 오가노이드 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 인간 오가노이드 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 인간 오가노이드 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• 아메리칸 유형 문화 컬렉션(ATCC)
• 사업 개요
• 기업 개요
• 제품 및 서비스
• 재무 상황(보고된 대로)
• 최근 동향
• 주요인물 상세
• SWOT 분석
• 사모 피셔 사이언티픽 주식회사
• STEMCELL Technologies Canada Inc.
• 머크 KGaA
• 코닝인코포레이텟드
• 바이오테크네 주식회사
• 나쁜 길 바이오 시스템즈 주식회사
• AMS 바이오테크놀러지(유럽) 주식회사
• 주식회사 Qkine
• PRIMACYT 세포배양 테크놀러지 주식회사

제16장 전략적 제안

제17장 리서치사에 대해 & 면책사항

영문목차

Global Human Organoids Market was valued at USD 510.24 Million in 2024 and is expected to reach USD 643.79 Million by 2030 with a CAGR of 4.15% during the forecast period. The global human organoids market is witnessing significant growth, driven by advancements in biotechnology, increasing demand for personalized medicine, and a rise in research activities focusing on disease modeling and drug discovery. Organoids, which are three-dimensional, miniature versions of human organs grown from stem cells, offer an innovative platform for studying human biology in a more precise and ethically sustainable way compared to traditional methods. This market is gaining traction across pharmaceutical, biotechnology, and academic sectors, offering promising avenues for research, drug testing, and regenerative medicine.

Key Market Drivers

Growth in Healthcare Industry

The growth of the global healthcare industry is a key driver of the human organoids market, propelling advancements in research, personalized medicine, and drug development. The healthcare industry ranks among the largest and most rapidly expanding sectors globally. In many developed countries, healthcare expenditures exceed 10 percent of the gross domestic product (GDP), representing a substantial portion of their economies. In the United States, healthcare spending increased by 2.7 percent in 2021, totaling USD 4.3 trillion, or USD 12,914 per capita. Healthcare spending also accounted for 18.3 percent of the nation's GDP. As healthcare systems worldwide continue to expand and evolve, there is a growing emphasis on innovative solutions to enhance the understanding of human biology, improve disease modeling, and accelerate the development of novel therapeutics. Human organoids-3D structures grown from stem cells that mimic the architecture and functionality of human organs-are becoming a critical tool in these advancements.

Key Market Challenges

High Costs of Development and Research

One of the key challenges facing the global human organoids market is the high costs associated with the development and research of these advanced biological models. The process of creating organoids, which involves cultivating stem cells to mimic the structure and function of human organs, requires cutting-edge technology, specialized expertise, and extensive laboratory resources. These factors contribute to significant upfront investment and ongoing operational expenses, which can hinder the widespread adoption and scalability of organoid technology.

The development of human organoids requires sophisticated equipment such as bioreactors, 3D cell culture systems, and precise imaging technologies, all of which are expensive to acquire and maintain. In addition, the cultivation of high-quality stem cells and the optimization of growth conditions to produce functional organoids are complex tasks that demand highly skilled personnel. Hiring and training researchers with the expertise to work with these intricate models further adds to the cost burden.

Key Market Trends

Rising Applications in Drug Discovery and Testing

The rising applications of human organoids in drug discovery and testing are emerging as a significant trend in the global human organoids market, transforming the way pharmaceutical research is conducted. Human organoids, which are lab-grown 3D structures that mimic the physiological and functional properties of human organs, offer a highly accurate platform for studying human diseases, testing new drugs, and predicting treatment outcomes. This innovative technology is gaining widespread adoption in the pharmaceutical industry, driven by the need for more efficient, cost-effective, and reliable drug development processes. In 2020, 53 new medicines were introduced, and over 9,000 compounds are currently in various stages of development worldwide. The research-driven biopharmaceutical sector is estimated to have invested USD 198 billion globally in R&D during that year.

Key Market Players

• American Type Culture Collection (ATCC)
• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Canada Inc.
• Merck KGaA
• Corning Incorporated
• Bio-Techne Corporation
• ACROBIOSYSTEMS INC.
• AMS Biotechnology (Europe) Ltd
• Qkine Ltd.
• PRIMACYT Cell Culture Technology GmbH

Report Scope

In this report, the Global Human Organoids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Organoids Market, By Source:

• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Others

Human Organoids Market, By Organ Type:

• Stomach Models
• Intestine Models
• Liver Models
• Pancreatic Models
• Lung Models
• Brain Models
• Kidney Models
• Others

Human Organoids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Organoids Market.

Available Customizations:

Global Human Organoids Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Human Organoids Market

5. Global Human Organoids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others)
  • 5.2.2. By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Human Organoids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By Organ Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Organoids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Source
      • 6.3.1.2.2. By Organ Type
  • 6.3.2. Mexico Human Organoids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Source
      • 6.3.2.2.2. By Organ Type
  • 6.3.3. Canada Human Organoids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Source
      • 6.3.3.2.2. By Organ Type

7. Europe Human Organoids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By Organ Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Human Organoids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Source
      • 7.3.1.2.2. By Organ Type
  • 7.3.2. Germany Human Organoids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Source
      • 7.3.2.2.2. By Organ Type
  • 7.3.3. United Kingdom Human Organoids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Source
      • 7.3.3.2.2. By Organ Type
  • 7.3.4. Italy Human Organoids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Source
      • 7.3.4.2.2. By Organ Type
  • 7.3.5. Spain Human Organoids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Source
      • 7.3.5.2.2. By Organ Type

8. Asia Pacific Human Organoids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By Organ Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Organoids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Source
      • 8.3.1.2.2. By Organ Type
  • 8.3.2. India Human Organoids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Source
      • 8.3.2.2.2. By Organ Type
  • 8.3.3. South Korea Human Organoids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Source
      • 8.3.3.2.2. By Organ Type
  • 8.3.4. Japan Human Organoids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Source
      • 8.3.4.2.2. By Organ Type
  • 8.3.5. Australia Human Organoids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Source
      • 8.3.5.2.2. By Organ Type

9. South America Human Organoids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By Organ Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Human Organoids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Source
      • 9.3.1.2.2. By Organ Type
  • 9.3.2. Argentina Human Organoids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Source
      • 9.3.2.2.2. By Organ Type
  • 9.3.3. Colombia Human Organoids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Source
      • 9.3.3.2.2. By Organ Type

10. Middle East and Africa Human Organoids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Source
  • 10.2.2. By Organ Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Human Organoids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Source
      • 10.3.1.2.2. By Organ Type
  • 10.3.2. Saudi Arabia Human Organoids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Source
      • 10.3.2.2.2. By Organ Type
  • 10.3.3. UAE Human Organoids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Source
      • 10.3.3.2.2. By Organ Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Organoids Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1.1. American Type Culture Collection (ATCC)
• 15.1.2. Business Overview
• 15.1.3. Company Snapshot
• 15.1.4. Products & Services
• 15.1.5. Financials (As Reported)
• 15.1.6. Recent Developments
• 15.1.7. Key Personnel Details
• 15.1.8. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. STEMCELL Technologies Canada Inc.
• 15.4. Merck KGaA
• 15.5. Corning Incorporated
• 15.6. Bio-Techne Corporation
• 15.7. ACROBIOSYSTEMS INC.
• 15.8. AMS Biotechnology (Europe) Ltd
• 15.9. Qkine Ltd.
• 15.10. PRIMACYT Cell Culture Technology GmbH

16. Strategic Recommendations

17. About Us & Disclaimer